GRM5 and Alzheimer disease: Additionally, activation of NF-κB can be associated with robust expression of proinflammatory markers in astrocytes that further exacerbate AD pathology [79] and indeed astrocytic mGluR5 blockade prevents the secretion of the inflammatory cytokines Interleukin 6 and 8 by astrocytes [80].